Literature DB >> 19376704

Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.

Dalip Kumar1, Gautam Patel, Emmanuel O Johnson, Kavita Shah.   

Abstract

A series of 3,5-disubstituted-1,2,4-oxadiazoles were synthesized and evaluated for their in vitro anti-proliferative activities against various cancer cell lines. Formation of 1,2,4-oxadiazole ring was accomplished by the reaction of amidoxime with carboxylic acids. The in vitro cytotoxic effects of 3,5-disubstituted-1,2,4-oxadiazoles have been demonstrated across a wide array of tumor cell types and a few compounds exhibited specificity towards pancreatic (3f, 3h, 3j, and 3k) and prostate (3n) cancer cells. Among the prepared 3,5-disubstituted-1,2,4-oxadiazoles, compound 3n is the most selective (>450-fold) and compound 3p is the most cytotoxic (10nM) against prostate cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376704     DOI: 10.1016/j.bmcl.2009.03.158

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

Review 1.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

Authors:  Roland E Dolle; Bertrand Le Bourdonnec; Karin Worm; Guillermo A Morales; Craig J Thomas; Wei Zhang
Journal:  J Comb Chem       Date:  2010-10-05

2.  Antiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotype.

Authors:  Mikhail Krasavin; Andrey V Sosnov; Ruben Karapetian; Igor Konstantinov; Olga Soldatkina; Elena Godovykh; Fedor Zubkov; Ruoli Bai; Ernest Hamel; Andrei A Gakh
Journal:  Bioorg Med Chem Lett       Date:  2014-08-08       Impact factor: 2.823

3.  Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor.

Authors:  Kaitlin J Basham; Vasudev R Bhonde; Collin Kieffer; James B C Mack; Matthew Hess; Bryan E Welm; Ryan E Looper
Journal:  Bioorg Med Chem Lett       Date:  2014-04-13       Impact factor: 2.823

4.  Diaminoglyoxime as a versatile reagent in the synthesis of bis(1,2,4-oxadiazoles), 1,2,4-oxadiazolyl-quinazolines and 1,2,4-oxadiazolyl-benzothiazinones.

Authors:  Rahim Hosseinzadeh Khanmiri; Abolghasem Moghimi; Ahmad Shaabani; Hassan Valizadeh; Seik Weng Ng
Journal:  Mol Divers       Date:  2014-08-13       Impact factor: 2.943

5.  1,2,3-Triazoles as Amide Bioisosteres: Discovery of a New Class of Potent HIV-1 Vif Antagonists.

Authors:  Idrees Mohammed; Indrasena Reddy Kummetha; Gatikrushna Singh; Natalia Sharova; Gianluigi Lichinchi; Jason Dang; Mario Stevenson; Tariq M Rana
Journal:  J Med Chem       Date:  2016-08-10       Impact factor: 7.446

6.  Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs.

Authors:  Bhaskar C Das; Xiang-Ying Tang; Patrick Rogler; Todd Evans
Journal:  Tetrahedron Lett       Date:  2012-08-01       Impact factor: 2.415

7.  Novel biphenyl-substituted 1,2,4-oxadiazole ferroelectric liquid crystals: synthesis and characterization.

Authors:  Mahabaleshwara Subrao; Dakshina Murthy Potukuchi; Girish Sharada Ramachandra; Poornima Bhagavath; Sangeetha G Bhat; Srinivasulu Maddasani
Journal:  Beilstein J Org Chem       Date:  2015-02-11       Impact factor: 2.883

8.  Metal-free hydroarylation of the side chain carbon-carbon double bond of 5-(2-arylethenyl)-3-aryl-1,2,4-oxadiazoles in triflic acid.

Authors:  Anna S Zalivatskaya; Dmitry S Ryabukhin; Marina V Tarasenko; Alexander Yu Ivanov; Irina A Boyarskaya; Elena V Grinenko; Ludmila V Osetrova; Eugeniy R Kofanov; Aleksander V Vasilyev
Journal:  Beilstein J Org Chem       Date:  2017-05-11       Impact factor: 2.883

9.  SET activation of nitroarenes by 2-azaallyl anions as a straightforward access to 2,5-dihydro-1,2,4-oxadiazoles.

Authors:  Dong Zou; Lishe Gan; Fan Yang; Huan Wang; Youge Pu; Jie Li; Patrick J Walsh
Journal:  Nat Commun       Date:  2021-12-03       Impact factor: 14.919

10.  Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.

Authors:  Ahmet Özdemir; Belgin Sever; Mehlika Dilek Altıntop; Halide Edip Temel; Özlem Atlı; Merve Baysal; Fatih Demirci
Journal:  Molecules       Date:  2017-07-04       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.